What changed
Markel Insurance entered an adverse development cover reinsurance agreement with Enstar covering $4.8 billion of subject reserves in its run-off global reinsurance business and certain exited lines. Markel retains the first $2.6 billion and retrocedes the next $2.3 billion to Enstar, obtaining $1.2 billion of adverse loss development coverage above the subject reserves while paying Enstar a $120 million risk premium. The transaction, expected to close by the end of the fourth quarter of 2026 pending regulatory approval, is expected to have an immaterial impact on fourth quarter underwriting results. Markel will maintain claims control.